CN1389462A - 大叶蒟素及其同系物,和在制备药物组合物中的应用 - Google Patents
大叶蒟素及其同系物,和在制备药物组合物中的应用 Download PDFInfo
- Publication number
- CN1389462A CN1389462A CN02136003A CN02136003A CN1389462A CN 1389462 A CN1389462 A CN 1389462A CN 02136003 A CN02136003 A CN 02136003A CN 02136003 A CN02136003 A CN 02136003A CN 1389462 A CN1389462 A CN 1389462A
- Authority
- CN
- China
- Prior art keywords
- homologue
- laetispicine
- application
- amides
- medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
- C07D317/60—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
本发明属中药制药领域,涉及一种从植物大叶蒟中分离到的酰胺类化合物,具有式(1)结构,本发明经对小鼠动物实验结果证实,有明显的抗抑郁作用和镇静、镇痛作用,其抗抑郁强度约为氟西汀的5倍。本发明大叶蒟素及其同系物可作为药物活性成分制成胶囊、片剂、注射剂、口服液、缓释剂等制剂。
Description
技术领域
本发明属中药制药领域,涉及一种从植物大叶蒟中分离到的酰胺类化合物,和在制备药物组合物中的应用。
背景技术
当今世界危害人类健康的5大疾病之一的抑郁症、精神障碍及因此导致的早老性痴呆(阿尔茨海默病),已经给人类社会带来沉重的负担。中国卫生部证实,精神障碍在我国疾病总负担的排名中居首位,已超过了心脑血管、呼吸系统及恶性肿瘤等疾患。
近年来风靡于欧美及日本等国的新型天然保健药品卡瓦卡瓦(Kavakava),已作为主要用药临床治疗放松紧张情绪、镇静及抗抑郁等。其植物来源为生长于南太平洋岛国的卡瓦胡椒(Piper methys-ticum Forst)。据报道卡瓦卡瓦在临床治疗中还有不尽人意之处,另有报道在我国天然药物中发掘抗抑郁和治疗精神障碍性疾病的药物已形成研究热点。有研究发现从中药大叶蒟中醇提取乙酸乙酯萃取之抽提物具镇痛、镇静和抗抑郁作用。
发明内容
本发明的目的是提供式(1)的酰胺类新化合物大叶蒟素及其同系物。
其中n=0-4,
n=1为大叶蒟素,
n=0,2,3和4为大叶蒟素同系物。
本发明可从植物大叶蒟(Piper laetispicum C.DC)中,按常规方法分离到,命名为大叶蒟素(laetispicine)。
本发明酰胺类新化合物大叶蒟素具抗抑郁作用,其抗抑郁强度约为氟西汀的5倍。
本发明酰胺类新化合物大叶蒟素其:化学名:N-isobutyl-11-(3,4-methylendioxyphenyl)-2E,4E,9E-undecatrienamide;分子式:C22H29NO3,无色针晶,mp93-94℃,HRMS 355.1257,MS m/z(R.Int.):355(M+,8.44),240(22.36),220(100),135(83.90),121(32.16),107(22.67),91(30.11),79(38.49),67(20.91)。λmaxMeOH nm(lgε):189(4.39),205.5(4.51),259.5(4.57)。表1为本发明氢、碳核磁共振数据(1HNMR(400MHZ,acetone-d6)和13CNMR(100MHZ,acetone-d6))。
本发明经动物实验结果证实,对小鼠有明显的抗抑郁作用和镇静、镇痛作用。表2为本发明对小鼠强迫游泳法抗抑郁作用的结果。
表2
差异有显著意义。表中Compound B和Compound C为同类对照药物,Fluoxetine为阳性对照药物。表1.
药物名称 | 剂量 | 不动时间X±SE |
ControlCompound BCompound CLaetispicineLaetispicineLaetispicineLaetispicineFluoxetine | 50mg/kg50mg/kg50mg/kg20mg/kg10mg/kg5mg/kg50mg/kg | 190.89±5.39156.67±7.36158.63±8.2917.67±5.3350.11±12.69131.0±8.86158.78±5.13113.44±10.10 |
C | 13CNMR(δppm) | 1HNMR(δppm) | Multiplicity(J in HZ) | COSY(1H-1H) |
1 | 166.38 | |||
2 | 124.47 | 5.96 | d(15.2) | H-3,H-4 |
3 | 140.45 | 7.10 | dd(15.2,10.8) | H-2,H-4 |
4 | 130.01 | 6.18 | dd(15.2,10.6) | H-3,H-5 |
5 | 141.95 | 6.06 | dt(14.8,6.8) | H-4,H-6 |
6 | 32.99 | 2.17 | br quartet | H-7,H-5 |
7 | 29.50 | 1.52 | m | H-6,H-8 |
8 | 32.64 | 2.06 | m | H-7,H-9 |
9 | 131.91 | 5.54 | m | H-8,H-11 |
10 | 130.80 | 5.54 | m | H-8,H-11 |
11 | 39.32 | 3.25 | d(5.2) | H-10,H-2,H-6 |
1 | 135.82 | m | ||
2 | 108.89 | 6.69 | O-CH2-O | |
3 | 148.72 | |||
4 | 146.83 | |||
5 | 109.70 | 6.74 | H-6,O-CH2-O | |
6 | 122.05 | 6.64 | H-5,H-2,H-11 | |
1″ | 47.45 | 3.08 | t(6.6) | H-2″,NH |
2″ | 29.22 | 1.78 | 7 linemultiplet(6.4) | H-3″,H-4″,H-1″ |
3″,4″ | 20.56 | 0.9 | d(6.8) | H-2″ |
O-CH2-O | 101.78 | 5.94 | s | H-5,H-2 |
NH | 7.1 | br | H-1″ |
本发明大叶蒟素及其同系物可作为药物活性成分制成胶囊、片剂、注射剂、口服液、缓释剂等制剂。
附图说明图1是本发明对小鼠强迫游泳法抗抑郁作用的结果,其中1是阴性对照,
2、3是同类药物对照,
4、5、6、7是本发明大叶蒟素,
8是阳性药物对照。
Claims (5)
1、一种酰胺类化合物大叶蒟素及其同系物,其特征在于具有式(1)的结构。
其中n=0-4,
n=1为大叶蒟素,
2、根据权利要求1所述的酰胺类化合物大叶蒟素及其同系物,其特征在于n=0,2,3和4时为大叶蒟素同系物。
3、酰胺类化合物大叶蒟素及其同系物在制备治疗抑郁症药物中的应用。
4、酰胺类化合物大叶蒟素及其同系物在制备治疗精神障碍药物中的应用。
5、酰胺类化合物大叶蒟素及其同系物在制备治疗早老性痴呆药物中的应用。
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN02136003A CN1389462A (zh) | 2002-07-12 | 2002-07-12 | 大叶蒟素及其同系物,和在制备药物组合物中的应用 |
US10/616,605 US6858648B2 (en) | 2002-07-12 | 2003-07-10 | Laetispicine and laetispicine analogues, methods of use and preparation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN02136003A CN1389462A (zh) | 2002-07-12 | 2002-07-12 | 大叶蒟素及其同系物,和在制备药物组合物中的应用 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN1389462A true CN1389462A (zh) | 2003-01-08 |
Family
ID=4748462
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN02136003A Pending CN1389462A (zh) | 2002-07-12 | 2002-07-12 | 大叶蒟素及其同系物,和在制备药物组合物中的应用 |
Country Status (2)
Country | Link |
---|---|
US (1) | US6858648B2 (zh) |
CN (1) | CN1389462A (zh) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006000158A1 (fr) * | 2004-06-25 | 2006-01-05 | Fudan University | Utilisation de laetispicine pour la fabrication d'une composition pharmaceutique |
CN100436407C (zh) * | 2003-03-20 | 2008-11-26 | 蒋毅 | 大叶蒟有效部位的制备及其在医疗、保健领域的应用 |
WO2010091540A1 (zh) * | 2009-02-11 | 2010-08-19 | 中国科学院上海药物研究所 | 一种砜基四氮唑类化合物及其制备方法和制备大叶蒟素的用途 |
CN102240281A (zh) * | 2010-05-12 | 2011-11-16 | 天津天士力制药股份有限公司 | 5′-甲氧基-3′,4′-次甲二氧基桂皮酸异丁基酰胺在制备抗抑郁药物中的应用 |
CN102731468A (zh) * | 2011-04-01 | 2012-10-17 | 中国科学院上海药物研究所 | 芳香丙烯类天然产物的衍生物及其制备方法和用途 |
CN102775394A (zh) * | 2011-05-12 | 2012-11-14 | 天士力制药集团股份有限公司 | 一种酰胺类化合物及其制备方法和应用 |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9132135B2 (en) * | 2004-09-24 | 2015-09-15 | University Of Maryland, Baltimore | Method of treating organophosphorous poisoning |
CA2583439C (en) * | 2004-09-24 | 2016-05-10 | University Of Maryland, Baltimore | Method of treating organophosphorous poisoning |
CN100356940C (zh) * | 2004-12-01 | 2007-12-26 | 蒋毅 | 制备大叶蒟提取物的方法、提取物及其应用 |
WO2009078035A1 (en) * | 2007-12-17 | 2009-06-25 | Council Of Scientific & Industrial Research | Extract of piper betel leaves for the treatment of human malignancies by inducing oxidative stress |
TWI546537B (zh) * | 2009-05-19 | 2016-08-21 | 維維亞生技公司 | 提供針對血液腫瘤之體外個人化藥物測試之方法 |
CN102850317B (zh) * | 2011-06-27 | 2017-02-08 | 天士力制药集团股份有限公司 | 一种取代桂皮酰胺衍生物、制备方法及其应用 |
CN104076116B (zh) * | 2014-06-27 | 2015-06-17 | 江苏省中医院 | 一种测定血浆中5’-甲氧基-3’, 4’-亚甲二氧苯基桂皮酸异丁基酰胺浓度的方法 |
CN113209165A (zh) * | 2017-11-01 | 2021-08-06 | 苏州颐华生物医药技术股份有限公司 | 一种大叶蒟提取物及其制备方法与应用 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5536506A (en) * | 1995-02-24 | 1996-07-16 | Sabinsa Corporation | Use of piperine to increase the bioavailability of nutritional compounds |
US5693327A (en) * | 1995-07-12 | 1997-12-02 | Shah; Eladevi | Herbal compositions |
US6080410A (en) * | 1997-03-17 | 2000-06-27 | Natrol, Inc. | Method for reducing daily stress and anxiety in adults |
GB9815177D0 (en) * | 1998-07-13 | 1998-09-09 | King S College London | Treatment of skin disorders |
US6312735B1 (en) * | 2001-02-09 | 2001-11-06 | Sarfaraz K. Niazi | Method for instantaneous removal of warts and moles |
-
2002
- 2002-07-12 CN CN02136003A patent/CN1389462A/zh active Pending
-
2003
- 2003-07-10 US US10/616,605 patent/US6858648B2/en not_active Expired - Fee Related
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100436407C (zh) * | 2003-03-20 | 2008-11-26 | 蒋毅 | 大叶蒟有效部位的制备及其在医疗、保健领域的应用 |
WO2006000158A1 (fr) * | 2004-06-25 | 2006-01-05 | Fudan University | Utilisation de laetispicine pour la fabrication d'une composition pharmaceutique |
CN1332656C (zh) * | 2004-06-25 | 2007-08-22 | 复旦大学 | 化合物大叶蒟素在制备药物组合物中的应用 |
WO2010091540A1 (zh) * | 2009-02-11 | 2010-08-19 | 中国科学院上海药物研究所 | 一种砜基四氮唑类化合物及其制备方法和制备大叶蒟素的用途 |
CN101798297B (zh) * | 2009-02-11 | 2013-02-27 | 中国科学院上海药物研究所 | 大叶蒟素的化学合成方法 |
CN102240281A (zh) * | 2010-05-12 | 2011-11-16 | 天津天士力制药股份有限公司 | 5′-甲氧基-3′,4′-次甲二氧基桂皮酸异丁基酰胺在制备抗抑郁药物中的应用 |
CN102731468A (zh) * | 2011-04-01 | 2012-10-17 | 中国科学院上海药物研究所 | 芳香丙烯类天然产物的衍生物及其制备方法和用途 |
CN102731468B (zh) * | 2011-04-01 | 2015-07-29 | 中国科学院上海药物研究所 | 芳香丙烯类天然产物的衍生物及其制备方法和用途 |
CN102775394A (zh) * | 2011-05-12 | 2012-11-14 | 天士力制药集团股份有限公司 | 一种酰胺类化合物及其制备方法和应用 |
CN102775394B (zh) * | 2011-05-12 | 2016-03-09 | 天士力制药集团股份有限公司 | 一种酰胺类化合物及其制备方法和应用 |
Also Published As
Publication number | Publication date |
---|---|
US6858648B2 (en) | 2005-02-22 |
US20040053994A1 (en) | 2004-03-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1389462A (zh) | 大叶蒟素及其同系物,和在制备药物组合物中的应用 | |
JP5226053B2 (ja) | ベンジルイソキノリン誘導体またはビスベンジルイソキノリン誘導体を含有する向精神薬、鎮痛薬および/または抗炎症薬、ならびに健康食品 | |
CN102014931A (zh) | 芍药甙的抗抑郁症用途、制备方法及其药物组合物 | |
JP2011504885A (ja) | 棗の環状アデノシン一リン酸から調製された抗うつ薬 | |
CN100436407C (zh) | 大叶蒟有效部位的制备及其在医疗、保健领域的应用 | |
Khan et al. | Antidiarrhoeal and bronchodilatory potential of Valeriana wallichii | |
Xia | History of Chinese medicinal wine | |
CN205569347U (zh) | 一种含铁皮石斛多糖微球的无糖口香糖 | |
CN1137702C (zh) | 中草药大叶蒟乙酸乙酯抽提物在制备精神类药物中的应用 | |
Carlson | Cannabis indica in 19th-century psychiatry | |
CN115887448B (zh) | 一种治疗失眠用组合物 | |
CN106389520A (zh) | 迷迭香中成药 | |
Robledo et al. | Effect of Caesalpinia spinosa (Molina) Kuntze extract P2Et on the resolution of cutaneous leishmaniasis in hamsters infected with Leishmania braziliensis | |
CN100486598C (zh) | 柴辛滴丸及其制备方法 | |
CN105396054A (zh) | 一种治疗癌症中度疼痛的栓剂及其制备方法 | |
Shyrko et al. | DOMESTIC PHARMACEUTICAL MARKET RESEARCH OF PHYTOPREPARATIONS WITH EXPECTORANT PROPERTIES | |
CN1634145A (zh) | 一种治疗脑炎、肝昏迷的醒脑静滴丸及其制备方法 | |
CN105902536B (zh) | 马钱苷在制备改善睡眠的药物中的应用 | |
CN101134066A (zh) | 治疗快速型心律失常症莲心滴丸的制备工艺 | |
TWI453027B (zh) | 主功效成分為大棗環腺苷單磷酸之藥物作為治療憂鬱症的用途 | |
Shih et al. | The effectiveness of coordination exercise on cognitive function in community-dwelling older adults: Oral Presentation | |
CN105030851B (zh) | 沙棘黄酮在制备增强阿片类药物药效的组合物中的应用 | |
Jackson | Recent Advances in Dermatology. Number Four | |
TW200922610A (en) | Oral medicine for treating depression | |
Kumar et al. | AN INTRODUCTION TO ORODISPERSED TABLETS |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C12 | Rejection of a patent application after its publication | ||
RJ01 | Rejection of invention patent application after publication |